Related Experiment Videos
Highly disabling cerebellar presentation in Huntington disease
F Squitieri1, G Pustorino, M Cannella
1Neurogenetics Unit, IRCCS Neuromed, Pozzilli (IS), University of Messina, Italy. neurogen@neuromed.it
European Journal of Neurology
|June 26, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mutant Huntingtin disrupts neurogenic and astroglial programs via the EZH2-Let-7g-LIN28 axis with rescue by epigenetic modulators.
Cell death and differentiation·2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemia.
European journal of neurology·2026
Low-carbohydrate ketogenic diet in Mc Ardle's disease: a single-blinded randomized controlled trial.
Journal of neurology·2025
Long term clinical follow-up and natural history in a cohort of Italian patients with GNE myopathy: the experience of a single centre.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025
Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD).
Neuromuscular disorders : NMD·2025
Association Between PM2.5 Components and Cerebral Hypoperfusion: A Mediation Role of Inflammatory Biomarkers.
European journal of neurology·2026
Age and Treatment Efficacy in Myasthenia Gravis: A Systematic Review, Meta-Analysis, and Meta-Regression.
European journal of neurology·2026
Thrombolysis in Patients With Mild Ischemic Stroke: A Comparative Effectiveness Study From the Norwegian Stroke Registry.
European journal of neurology·2026
Beyond Venous Inflammation: Vessel Wall Imaging of Intracranial Arteries in Neuro-Behçet's Syndrome.
European journal of neurology·2026
Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β.
Journal of Zhejiang University. Science. B·2026
Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran.
Neurodegenerative disease management·2026